Benitec Biopharma Inc.
SEC CIK 1808898 · BNTC · last insider filing 2026-06-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Buchi J Kevin | Director | filed 2020 - 2026 |
| Friedman David Matthew | Director | filed 2026 - 2026 |
| Mates Sharon | Director | filed 2025 - 2026 |
| Suvretta Capital Management, LLC | Director | filed 2024 - 2025 |
| Cowen Aaron | Director | filed 2024 - 2025 |
| Averill Master Fund, Ltd. | Director | filed 2024 - 2025 |
| Averill Madison Master Fund, Ltd. | Director | filed 2024 - 2025 |
| Smith Edward F | Director | filed 2020 - 2025 |
| Francis Peter | Director | filed 2020 - 2025 |
| Mehta Kishan | Director | filed 2024 - 2025 |
| Boston Megan | Director · Executive Director | filed 2020 - 2025 |
| Banks Jerel A. | Director · Chief Executive Officer | filed 2020 - 2025 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Mukadam Sophie | Chief Operating Officer | filed 2025 - 2025 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.